Skip to main content
Back
Watch Compare

Akso Health Group

Data quality: 100%
AHG
Nasdaq Services Business Services
$2.25
▼ $0.04 (-1.75%)
Mkt Cap: 1.93 B
Price
$2.25
Mkt Cap
1.93 B
Day Range
$2.20 — $2.29
52-Week Range
$0.83 — $2.50
Volume
147,790
Open $2.29
50D / 200D Avg
$1.75
28.43% above
50D / 200D Avg
$1.63
37.87% above

Quick Summary

Key Takeaways

Revenue grew 70.35% annually over 5 years — strong growth
Generating 7.23 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 441.73%
Capital efficient — spends only 0.18% of revenue on capex

Growth

Revenue Growth (5Y)
70.35%
Above sector avg (4.21%)
Revenue (1Y)512.08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-68.03%
Below sector avg (-15.74%)
ROIC-65.92%
Net Margin-914.06%
Op. Margin-1126.52%

Safety

Debt / Equity
N/A
Current Ratio1.53
Interest CoverageN/A

Valuation

PE (TTM)
-14.21
Below sector avg (-1.17)
P/B Ratio9.72
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -14.2 -1.2
P/B 9.7 1.4
ROE % -68.0 -15.7
Net Margin % -914.1 -18.3
Rev Growth 5Y % 70.4 4.2
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 512.08% Revenue Growth (3Y) 5.88%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 70.35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14.84 M Net Income (TTM) -135.67 M
ROE -68.03% ROA -63.84%
Gross Margin 1.00% Operating Margin -1126.52%
Net Margin -914.06% Free Cash Flow (TTM) 7.23 M
ROIC -65.92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.53
Interest Coverage N/A Asset Turnover 0.07
Working Capital 6.37 M Tangible Book Value 180.41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -14.21 Forward P/E N/A
P/B Ratio 9.72 P/S Ratio 129.87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.38%
Market Cap 1.93 B Enterprise Value 1.92 B
Per Share
EPS (Diluted TTM) -0.16 Revenue / Share 0.02
FCF / Share 0.01 OCF / Share 0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.18% FCF Conversion -5.33%
SBC-Adj. FCF 6.84 M Growth Momentum 441.73

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 14.78 M 2.41 M 13.18 M 6.31 M 1.75 M
Net Income -134.98 M -9.46 M -1.36 M -16.85 M -34.83 M
EPS (Diluted) -0.16 -0.07 -0.02 -0.28 -0.71
Gross Profit -281,526.0 122,132.0 1.27 M 916,226.0 —
Operating Income -166.30 M -8.64 M -14.27 M -15.94 M -30.90 M
EBITDA — — — — —
R&D Expenses — — — 421,186.0 441,405.0
SG&A Expenses 3.64 M — — — —
D&A 2.15 M — — 18,390.0 15,161.0
Interest Expense — 804,138.0 804,138.0 — —
Income Tax -30.80 M 24,988.0 17,549.0 131,433.0 482,976.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 214.95 M 142.02 M 20.46 M 50.68 M 31.69 M
Total Liabilities 15.80 M 3.59 M 11.62 M 38.39 M 14.41 M
Shareholders' Equity 199.12 M 138.37 M 8.73 M 12.28 M 17.27 M
Total Debt — — — — —
Cash & Equivalents 176.23 M 85.17 M 7.92 M 21.93 M 15.13 M
Current Assets 196.12 M 142.02 M 20.46 M 50.62 M 30.12 M
Current Liabilities 13.81 M 3.59 M 11.62 M 38.39 M 14.41 M